At the beginning of the year, Massimo filed his suit, alleging that dating back to 2013, he showed interest in a partnership to bring his medical-sensor technology to the Apple Watch. However, Mashimo claims that Apple began poaching its employees to steal expertise and trade secrets.
Now that Apple Watch Series 6 has come up with blood oxygen monitoring, Masimo has introduced a new court filing, claiming that by delaying the Apple lawsuit, adding to the iPhone manufacturer’s conflicting issues (via Bloomberg) Abusing its power to “capture the market”. .
Massimo said on Monday that postponing the case would “allow Apple to seize an important window of opportunity to occupy the emerging territory”. “As has been done in many other markets, Apple intends to use its critical resources and ecosystem to capture the market without any connection”, the censor-maker said.
Going further, Masimo stated that Apple would not answer their questions before Series 6 launched about it, including blood oxygen detection.
Mashimo claims that Apple disregarded earlier requests for information on whether the Watch Series 6 would have blood oxygen monitors. Massimo said Apple dismissed speculation about the feature as “Internet rumors” and claimed that the two sides were not in competition.
For Apple’s part, it wants to see if a review board will invalidate the patent infringement aspect of a lawsuit filed by Massimo before proceeding with the case. Apple did not respond to Bloomberg for a comment request.
On September 15, Apple delayed the patent aspect of the case, stating that a review board believed its invalid arguments could help ease issues for the court and would “undoubtedly reduce wasted resources.”
FTC: We use the auto affiliate link linked to income. more.
For more Apple news see 9to5Mac on YouTube: